ZHANG Ning, YANG Chenhao, ZHOU Liangrui, SUN Xiaohong, LIU Xiaohong, KANG Lin, LI Ji, LI Hailong. Cronkhite-Canada Syndrome Combined with Asymptomatic Novel Coronavirus Infection: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 406-412. DOI: 10.12290/xhyxzz.2023-0476
Citation: ZHANG Ning, YANG Chenhao, ZHOU Liangrui, SUN Xiaohong, LIU Xiaohong, KANG Lin, LI Ji, LI Hailong. Cronkhite-Canada Syndrome Combined with Asymptomatic Novel Coronavirus Infection: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 406-412. DOI: 10.12290/xhyxzz.2023-0476

Cronkhite-Canada Syndrome Combined with Asymptomatic Novel Coronavirus Infection: A Case Report

Funds: 

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-132

More Information
  • Corresponding author:

    SUN Xiaohong, E-mail: sunxiaoh2010@ 126.com

  • Received Date: October 15, 2023
  • Accepted Date: October 24, 2023
  • Issue Publish Date: March 29, 2024
  • This article presents a case study of a patient who had Cronkhite-Canada syndrome in combination with an asymptomatic novel coronavirus infection. The patient exhibited clinical symptoms of loss of appetite, hair and nail loss, and skin pigmentation. Digestive endoscopy revealed widespread and varying-sized polypoid changes in the mucosa of the stomach, duodenum, and colon. During the course of the illness, the patient tested positive for novel coronavirus nucleic acid. Treatment with moderate doses of prednisone resulted in the patient's hair regrowth and decreased skin hypopigmentation. The article provides a summary of the patient's diagnosis and treatment and a review of relevant literature, with the aim of enhancing clinicians' understanding of the disease.
  • [1]
    Vashistha N, Chakravarty S, Singhal D. Cronkhite-Canada syndrome[J]. Gastrointest Endosc, 2017, 86(5): 922-923. DOI: 10.1016/j.gie.2017.05.028
    [2]
    CRONKHITE L W, Jr, CANADA W J. Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia[J]. N Engl J Med, 1955, 252(24): 1011-1015. DOI: 10.1056/NEJM195506162522401
    [3]
    Slavik T, Montgomery E A. Cronkhite-Canada syndrome six decades on: the many faces of an enigmatic disease[J]. J Clin Pathol, 2014, 67(10): 891-897. DOI: 10.1136/jclinpath-2014-202488
    [4]
    Lu Y Y, Huang F X, Wang Y W, et al. Clinical and endoscopic characteristics of Chinese Cronkhite-Canada syndrome patients: a retrospective study of 103 cases[J]. Dig Dis, 2021, 39(5): 488-495. DOI: 10.1159/000514354
    [5]
    Miyawaki K, Komori T, Ishida Y, et al. Cronkhite-Canada syndrome mimicking COVID-19-related symptoms[J]. Acta Derm Venereol, 2022, 102: adv00812. DOI: 10.2340/actadv.v102.3402
    [6]
    Yoshimoto T, Okamoto T, Fukuda K. Cronkhite-Canada syndrome: a rare COVID-19 mimicker[J]. Am J Gastroenterol, 2021, 116(8): 1765. DOI: 10.14309/ajg.0000000000001254
    [7]
    Øksnes M, Husebye E S. Approach to the patient: diagnosis of primary adrenal insufficiency in adults[J]. J Clin Endocrinol Metab, 2023, 109(1): 269-278. DOI: 10.1210/clinem/dgad402
    [8]
    Hashim M, Athar S, Gaba W H. New onset adrenal insufficiency in a patient with COVID-19[J]. BMJ Case Rep, 2021, 14(1): e237690. DOI: 10.1136/bcr-2020-237690
    [9]
    Kumar R, Guruparan T, Siddiqi S, et al. A case of adrenal infarction in a patient with COVID 19 infection[J]. BJR Case Rep, 2020, 6(3): 20200075.
    [10]
    Siejka A, Barabutis N. Adrenal insufficiency in the COVID-19 era[J]. Am J Physiol Endocrinol Metab, 2021, 320(4): E784-E785. DOI: 10.1152/ajpendo.00061.2021
    [11]
    Kanczkowski W, Evert K, Stadtmüller M, et al. COVID-19 targets human adrenal glands[J]. Lancet Diabetes Endocrinol, 2022, 10(1): 13-16. DOI: 10.1016/S2213-8587(21)00291-6
    [12]
    Goto A. Cronkhite-Canada syndrome: epidemiological study of 110 cases reported in Japan[J]. Nihon Geka Hokan, 1995, 64(1): 3-14.
    [13]
    Murata I, Yoshikawa I, Endo M, et al. Cronkhite-Canada syndrome: report of two cases[J]. J Gastroenterol, 2000, 35(9): 706-711. DOI: 10.1007/s005350070051
    [14]
    Ikeda K, Sannohe Y, Murayama H. A case of Cronkhite-Canada syndrome developing after hemi-colectomy[J]. Endoscopy, 1981, 13(6): 251-253. DOI: 10.1055/s-2007-1021699
    [15]
    Zong Y, Zhao H Y, Yu L, et al. Case report-malignant transformation in Cronkhite-Canada syndrome polyp[J]. Medicine (Baltimore), 2017, 96(6): e6051. DOI: 10.1097/MD.0000000000006051
    [16]
    Wen X H, Wang L, Wang Y X, et al. Cronkhite-Canada syndrome: report of six cases and review of literature[J]. World J Gastroenterol, 2014, 20(23): 7518-7522. DOI: 10.3748/wjg.v20.i23.7518
    [17]
    Takeuchi Y, Yoshikawa M, Tsukamoto N, et al. Cronkhite-Canada syndrome with colon cancer, portal thrombosis, high titer of antinuclear antibodies, and membranous glomerulonephritis[J]. J Gastroenterol, 2003, 38(8): 791-795. DOI: 10.1007/s00535-002-1148-6
    [18]
    Fan R Y, Wang X W, Xue L J, et al. Cronkhite-Canada syndrome polyps infiltrated with IgG4-positive plasma cells[J]. World J Clin Cases, 2016, 4(8): 248-252. DOI: 10.12998/wjcc.v4.i8.248
    [19]
    Watanabe C, Komoto S, Tomita K, et al. Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite-Canada syndrome: a Japanese nationwide survey[J]. J Gastroenterol, 2016, 51(4): 327-336. DOI: 10.1007/s00535-015-1107-7
    [20]
    Kato K, Ishii Y, Mazaki T, et al. Spontaneous regression of polyposis following abdominal colectomy and Helicobacter pylori eradication for Cronkhite-Canada syndrome[J]. Case Rep Gastroenterol, 2013, 7(1): 140-146. DOI: 10.1159/000350321
    [21]
    Boland B S, Bagi P, Valasek M A, et al. Cronkhite Canada syndrome: significant response to infliximab and a possible Clue to pathogenesis[J]. Am J Gastroenterol, 2016, 111(5): 746-748.
    [22]
    Ho V, Banney L, Falhammar H. Hyperpigmentation, nail dystrophy and alopecia with generalised intestinal polyposis: Cronkhite-Canada syndrome[J]. Australas J Dermatol, 2008, 49(4): 223-225. DOI: 10.1111/j.1440-0960.2008.00474.x
    [23]
    Wu Z Y, Sang L X, Chang B. Cronkhite-Canada syndrome: from clinical features to treatment[J]. Gastroenterol Rep (Oxf), 2020, 8(5): 333-342. DOI: 10.1093/gastro/goaa058
    [24]
    李媛, 罗涵青, 吴东, 等. Cronkhite-Canada综合征临床病理学分析及IgG4阳性浆细胞浸润的意义[J]. 中华病理学杂志, 2018, 47(10): 753-757.

    Li Y, Luo H Q, Wu D, et al. Clinicopathologic features of Cronkhite-Canada syndrome and the significance of IgG4-positive plasma cells infiltration[J]. Chin J Pathol, 2018, 47(10): 753-757.
    [25]
    Wallenhorst T, Pagenault M, Bouguen G, et al. Small-bowel video capsule endoscopic findings of Cronkhite-Canada syndrome[J]. Gastrointest Endosc, 2016, 84(4): 739-740. DOI: 10.1016/j.gie.2016.04.004
    [26]
    Murata M, Bamba S, Takahashi K, et al. Application of novel magnified single balloon enteroscopy for a patient with Cronkhite-Canada syndrome[J]. World J Gastroenterol, 2017, 23(22): 4121-4126. DOI: 10.3748/wjg.v23.i22.4121
    [27]
    Jha A K, Kumar A, Singh S K, et al. Panendoscopic characterization of Cronkhite-Canada syndrome[J]. Med J Armed Forces India, 2018, 74(2): 196-200. DOI: 10.1016/j.mjafi.2017.03.007
    [28]
    Bettington M, Brown I S, Kumarasinghe M P, et al. The challenging diagnosis of Cronkhite-Canada syndrome in the upper gastrointestinal tract: a series of 7 cases with clinical follow-up[J]. Am J Surg Pathol, 2014, 38(2): 215-223. DOI: 10.1097/PAS.0000000000000098
    [29]
    Nagata J, Kijima H, Hasumi K, et al. Adenocarcinoma and multiple adenomas of the large intestine, associated with Cronkhite-Canada syndrome[J]. Dig Liver Dis, 2003, 35(6): 434-438. DOI: 10.1016/S1590-8658(03)00160-9
    [30]
    Karasawa H, Miura K, Ishida K, et al. Cronkhite-Canada syndrome complicated with huge intramucosal gastric cancer[J]. Gastric Cancer, 2009, 12(2): 113-117. DOI: 10.1007/s10120-009-0506-y
    [31]
    Watari J, Morita T, Sakurai J, et al. Endoscopically treated Cronkhite-Canada syndrome associated with minute intramucosal gastric cancer: an analysis of molecular pathology[J]. Dig Endosc, 2011, 23(4): 319-323. DOI: 10.1111/j.1443-1661.2011.01150.x
    [32]
    Maruno T, Kikuyama M. Cronkhite-Canada syndrome associated with sigmoid colon cancer[J]. Clin Gastroenterol Hepatol, 2011, 9(11): e118-e119. DOI: 10.1016/j.cgh.2011.06.003
    [33]
    Yuan B S, Jin X X, Zhu R M, et al. Cronkhite-Canada syndrome associated with rib fractures: a case report[J]. BMC Gastroenterol, 2010, 10: 121. DOI: 10.1186/1471-230X-10-121
    [34]
    Liu S, Ruan G C, You Y, et al. A striking flail chest: a rare manifestation of intestinal disease[J]. Intest Res, 2019, 17(1): 155-156. DOI: 10.5217/ir.2018.00132
    [35]
    Yasuda T, Ueda T, Matsumoto I, et al. Cronkhite-Canada syndrome presenting as recurrent severe acute pancreatitis[J]. Gastrointest Endosc, 2008, 67(3): 570-572. DOI: 10.1016/j.gie.2007.07.041
    [36]
    Yun S H, Cho J W, Kim J W, et al. Cronkhite-Canada syndrome associated with serrated adenoma and malignant polyp: a case report and a literature review of 13 Cronkhite-Canada syndrome cases in Korea[J]. Clin Endosc, 2013, 46(3): 301-305. DOI: 10.5946/ce.2013.46.3.301
    [37]
    Tong J Y, Wong A, Zhu D, et al. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis[J]. Otolaryngol Head Neck Surg, 2020, 163(1): 3-11. DOI: 10.1177/0194599820926473
    [38]
    Zhu X, Shi H Y, Zhou X N, et al. A case of recurrent Cronkhite-Canada syndrome containing colon cancer[J]. Int Surg, 2015, 100(3): 402-407. DOI: 10.9738/INTSURG-D-14-00003.1
    [39]
    Schulte S, Kütting F, Mertens J, et al. Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine[J]. BMC Gastroenterol, 2019, 19(1): 36. DOI: 10.1186/s12876-019-0944-x
  • Related Articles

    [1]YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer 68Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216
    [2]LIU Wanrong, TANG Hui, ZHOU Na, QIU Wei, LI Xiaoyuan, WANG Xiang, BAI Chunmei, ZHOU Jianfeng, ZHAO Lin. Incidence of COVID-19 in Patients with Tumor During the Omicron Pandemic[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1238-1245. DOI: 10.12290/xhyxzz.2023-0281
    [3]LIU Huan, HUANG Xiaoling, DAI Mengying, GUO Jiejie, GAO feng. Clinical Characteristics and Inflammatory Markers of Omicron BA.5.2 Variant Infection in Hospitalized Patients and Their Predictive Role in Disease Prognosis[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1038-1045. DOI: 10.12290/xhyxzz.2023-0055
    [4]KANG Junren, YU kang, LIU Yanping, YAN Jie, DOU Pan, HUA Xin, Beijing Quality Control and Improvement Center for Clinical Nutrition Therapy. Recommendations of Nutritional Treatment for Patients with COVID-19 Infection (2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 75-80. DOI: 10.12290/xhyxzz.2023-0019
    [5]ZHAO Zhe, TANG Yan, ZHOU Jingya, CHEN Xiaoguang, ZHANG Lei, CHEN Limeng, YUAN Tao. Analysis of Clinical Manifestations and Drug Therapies of Gitelman Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 277-286. DOI: 10.12290/xhyxzz.2021-0180
    [6]Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555
    [7]Working Group of 2019 Novel Coronavirus, Peking Union Medical College Hospital. Diagnosis and Clinical Management of 2019 Novel Coronavirus(2019-nCoV) Infection: An Operational Recommendation of Peking Union Medical College Hospital(V2.0)[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 672-675. DOI: 10.3969/j.issn.1674-9081.20200022
    [8]JIN Fan, XIE Jing, CHEN Rui, WANG Huan-ling. Progress of Remdesivir in the Treatment of Coronavirus Infection[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 659-664. DOI: 10.3969/j.issn.1674-9081.20200034
    [9]Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006
    [10]Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004
  • Cited by

    Periodical cited type(1)

    1. 宋鹏,赵永捷. Cronkhite-Canada综合征诊治进展. 天津医科大学学报. 2024(06): 567-570 .

    Other cited types(0)

Catalog

    Article Metrics

    Article views (205) PDF downloads (29) Cited by(1)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close